Latest Clinical Trials
Phase I Trial of High-Density Theta Burst Stimulation (hdTBS) National Institute on Drug Abuse (NIDA) NA
NOT YET RECRUITING
(Sep 21, 2026)
PHASE1 PET Imaging of Phosphodiesterase-4B (PDE4B) in Alcohol Use Disorder National Institute of Mental Health (NIMH) NA
RECRUITING
(Sep 16, 2026)
PHASE1 Stibium Metallicum Praeparatum D6 Versus Placebo in the Reduction of Paclitaxel-induced Peripheral Neurotoxicity University of Bern NA
NOT YET RECRUITING
(Sep 1, 2026)
PHASE3 Autogenous Mesenchymal Stem Cell Culture-Derived Signalling Molecules as Enhancers of Bone Formation in Bone Grafting Pontificia Universidade Católica do Rio Grande do Sul NA
NOT YET RECRUITING
(Sep 1, 2026)
PHASE1 MDMA for AUD/PTSD Comorbidity Carolina L Haass-Koffler NA
COMPLETED
(Sep 1, 2026)
PHASE2 Efficacy and Safety of Patidegib Gel 2% for Preventing Basal Cell Carcinomas on the Face of Adults With Gorlin Syndrome Sol-Gel Technologies, Ltd. NA
COMPLETED
(Sep 1, 2026)
PHASE3 Genetic Basis of the Risk and Consequences of Cannabis Exposure in Humans Yale University NA
RECRUITING
(Sep 1, 2026)
PHASE1 The Potential Therapeutic Effects of Psychedelic, N, N-dimethyltryptamine (DMT), on Alcohol Use Disorder (AUD) Yale University NA
RECRUITING
(Sep 1, 2026)
PHASE1 Vaporized Cannabis Administration and Co-Administration of Alcohol on Impairment Johns Hopkins University NA
RECRUITING
(Sep 1, 2026)
PHASE1 A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis) 89bio, Inc. NA
RECRUITING
(Sep 1, 2026)
PHASE3 The Effects of Disulfiram (Antabuse®) on Visual Acuity in Patients With Retinal Degeneration University of Rochester NA
RECRUITING
(Sep 1, 2026)
PHASE1 Effect of Sublingual Formulation of Dexmedetomidine Hydrochloride (HCl) (BXCL501) - Outpatient Study Pharmacotherapies for Alcohol and Substance Use Disorders Alliance NA
RECRUITING
(Sep 1, 2026)
PHASE1 A Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain Tumors Neonc Technologies, Inc. NA
RECRUITING
(Sep 1, 2026)
PHASE1 A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH 89bio, Inc. NA
RECRUITING
(Sep 1, 2026)
PHASE3 A Clinical Study of Efinopegdutide in People With Compensated Cirrhosis Due to Steatohepatitis (MK-6024-017) Merck Sharp & Dohme LLC NA
COMPLETED
(Sep 1, 2026)
PHASE2 Evaluating Cannabidiol as a Novel Anticraving Medication for Alcohol Use Disorder Centre for Addiction and Mental Health NA
ACTIVE NOT RECRUITING
(Sep 1, 2026)
PHASE2 Pregnenolone to Target Concurrent PTSD and Stress Induced Alcohol Use in Veterans: A Dose Finding Study Pharmacotherapies for Alcohol and Substance Use Disorders Alliance NA
NOT YET RECRUITING
(Sep 1, 2026)
PHASE2 LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis Boehringer Ingelheim NA
RECRUITING
(Sep 1, 2026)
PHASE3 LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis Boehringer Ingelheim NA
RECRUITING
(Sep 1, 2026)
PHASE3 A Study to Test the Effects of Nezavist at Different Doses in Healthy Adults Lohocla Research Corporation NA
TERMINATED
(Sep 1, 2026)
PHASE1 Diclofenac Dose Response Study University of Maryland, Baltimore NA
COMPLETED
(Sep 1, 2026)
PHASE1 PT150 Drug for Use in Alcohol Use Disorder Pop Test Oncology LLC NA
RECRUITING
(Sep 1, 2026)
PHASE1 A-TANGO Phase 2 Study Yaqrit Ltd NA
RECRUITING
(Sep 1, 2026)
PHASE2 Mediterranean Diet and Inequality in Early Breast Cancer Esbjerg Hospital - University Hospital of Southern Denmark NA
RECRUITING
(Sep 1, 2026)
PHASE2 Orexin Receptor Antagonism for the Treatment of Alcohol Use Disorder and Stress-Related Drinking Ohio State University NA
RECRUITING
(Sep 1, 2026)
PHASE2 Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized Controlled Trial for Alcohol Use Disorder (CRAVE) VA Office of Research and Development NA
RECRUITING
(Sep 1, 2026)
PHASE3 A Study of Brenipatide in Participants With Alcohol Use Disorder Eli Lilly and Company NA
RECRUITING
(Sep 1, 2026)
PHASE3 A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder Eli Lilly and Company NA
RECRUITING
(Sep 1, 2026)
PHASE3 Phase 1 Study of Intravaginal KB15A ZabBio Inc. NA
RECRUITING
(Sep 1, 2026)
PHASE1 Semaglutide (SEMA) for Alcohol Use Disorder (AUD) After Metabolic and Bariatric Surgery (MBS) Yale University NA
ACTIVE NOT RECRUITING
(Sep 1, 2026)
PHASE1 Low Dose Naltrexone (LDN) for Management of Fatigue in Prostate Cancer Patients on Androgen Deprivation Therapy (ADT) University of Arkansas NA
RECRUITING
(Sep 1, 2026)
PHASE2 Cannabidiol and Alcohol Use Disorder Phenotypes University of Colorado, Denver NA
RECRUITING
(Sep 1, 2026)
PHASE2 Psilocybin-Assisted Psychotherapy for the Treatment of Severe Alcohol Use Disorder Brigham and Women's Hospital NA
NOT YET RECRUITING
(Sep 1, 2026)
PHASE2 Acute Effects of Alcohol on PET Imaging of Phosphodiesterase-4B (PDE4B) National Institute of Mental Health (NIMH) NA
RECRUITING
(Aug 13, 2026)
PHASE1 Environment and Alcohol: A Pilot Study National Institute on Drug Abuse (NIDA) NA
RECRUITING
(Aug 10, 2026)
PHASE1 Suvorexant for Alcohol Use Disorder (AUD): Neural Mechanisms National Institute on Alcohol Abuse and Alcoholism (NIAAA) NA
RECRUITING
(Aug 6, 2026)
PHASE1, PHASE2 Double-blind, Randomized, Placebo-controlled Trial of Ganaxolone in CDKL5 Deficiency Patients 6 Months to Less Than 2 Years Old Immedica Pharma AB NA
NOT YET RECRUITING
(Aug 1, 2026)
PHASE3 Neurobehavioral Mechanisms of Psilocybin-assisted Treatment for AUD NYU Langone Health NA
RECRUITING
(Aug 1, 2026)
PHASE2 Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i. MedSIR NA
RECRUITING
(Aug 1, 2026)
PHASE3 Choline and Iron Deficiency University of Minnesota NA
RECRUITING
(Aug 1, 2026)
PHASE2, PHASE3 PsiloStudy: Psilocybin With Psychological Support (Psi-PS) for Military Veterans and First Responders With Co-occurring PTSD & Alcohol Use Disorder (AUD) Nathan Brashares Sackett NA
ACTIVE NOT RECRUITING
(Aug 1, 2026)
PHASE2 Renal Artery Denervation Assessment Without Antihypertensive Medication Regimen (RADAR) Ablative Solutions, Inc. NA
NOT YET RECRUITING
(Aug 1, 2026)
PHASE3 Cannabidiol as an Adjunct Treatment for Alcohol Withdrawal and Craving Johns Hopkins University NA
NOT YET RECRUITING
(Aug 1, 2026)
PHASE2, PHASE3 Methylphenidate and Response to Alcohol Cues University of Florida NA
NOT YET RECRUITING
(Aug 1, 2026)
PHASE2 Role of Metal Ion Transporter ZIP8 in Alcohol-Related Behaviors National Institute on Alcohol Abuse and Alcoholism (NIAAA) NA
RECRUITING
(Jul 30, 2026)
PHASE1 Tirzepatide in MetALD National Institute on Alcohol Abuse and Alcoholism (NIAAA) NA
RECRUITING
(Jul 16, 2026)
PHASE2 Emergency Department-Initiated Medications for Alcohol Use Disorder Yale University NA
RECRUITING
(Jul 1, 2026)
PHASE3 DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment QuantumLeap Healthcare Collaborative NA
RECRUITING
(Jul 1, 2026)
PHASE2 Hyperbaric Oxygen Treatment for Veterans With Traumatic Brain Injury University of South Florida NA
RECRUITING
(Jul 1, 2026)
PHASE3 Impact of Daily Oral Cannabis Doses in Patients With Cancer Shanna Babalonis, PhD NA
RECRUITING
(Jul 1, 2026)
PHASE1 A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease GlaxoSmithKline NA
RECRUITING
(Jul 1, 2026)
PHASE2 Aging Resilience Through Microbiota Optimization and Regulation Gonzalo Jorquera, PhD NA
ACTIVE NOT RECRUITING
(Jul 1, 2026)
PHASE1 Study of Tirzepatide for Recovery and Alcohol Use Management Brigham and Women's Hospital NA
RECRUITING
(Jul 1, 2026)
PHASE2 A Study to Evaluate Mazdutide Compared With Placebo in Participants With Alcohol Use Disorder Eli Lilly and Company NA
COMPLETED
(Jul 1, 2026)
PHASE2 Focusing on the Menopausal Transition to Improve Mid-Life Women's Health University of Colorado, Denver NA
RECRUITING
(Jul 1, 2026)
PHASE2, PHASE3 Comparative Efficacy of IV Dexamethasone vs. Nebulized Terbutaline for Renal Colic Pain in the ED University of Monastir NA
NOT YET RECRUITING
(Jul 1, 2026)
PHASE3 Integrated Therapies for Alcohol Use in Alcohol-associated Liver Disease (ITAALD) Trial Samer Gawrieh NA
RECRUITING
(Jul 1, 2026)
PHASE2 Periprostatic Neurolysis in Prostate Cancer University of Texas Southwestern Medical Center NA
ACTIVE NOT RECRUITING
(Jul 1, 2026)
PHASE1 Combination Therapy for Alcohol Use Disorder Johns Hopkins University NA
NOT YET RECRUITING
(Jul 1, 2026)
PHASE2 Cognitive Strategies in Early Psychosis 2 University of Minnesota NA
RECRUITING
(Jul 1, 2026)
PHASE3 A Study of the Efficacy, Safety and Pharmacokinetics of RPH-051 and Perjeta® in Combination With Trastuzumab and Docetaxel as the 1st Line Therapy in Patients With HER2-positive Breast Cancer R-Pharm NA
ACTIVE NOT RECRUITING
(Jul 1, 2026)
PHASE3 Cannabidiol for Reducing Drinking in Alcohol Use Disorder Hôpital le Vinatier NA
TERMINATED
(Jun 1, 2026)
PHASE2 Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gain After Liver Transplant University of Virginia NA
RECRUITING
(Jun 1, 2026)
PHASE2 Influence of Mavoglurant on Alcohol Craving and Drinking in Heavy Drinkers Yale University NA
RECRUITING
(Jun 1, 2026)
PHASE1 Study of Cannabidiol in Sanfilippo Syndrome Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center NA
RECRUITING
(Jun 1, 2026)
PHASE2, PHASE3 Study of Sunobinop on Alcohol Consumption in Alcohol Use Disorder Knoa Pharma LLC NA
COMPLETED
(Jun 1, 2026)
PHASE2 Study of Sunobinop on Craving in Alcohol Use Disorder Knoa Pharma LLC NA
COMPLETED
(Jun 1, 2026)
PHASE2 Study to Examine the Effect of Silicone Mouth Tape on Snoring and Mild Sleep Apnea. Johns Hopkins University NA
RECRUITING
(Jun 1, 2026)
PHASE2 Suvorexant for Treatment of AUD and PTSD Pharmacotherapies for Alcohol and Substance Use Disorders Alliance NA
RECRUITING
(Jun 1, 2026)
PHASE2 A Clinical Trial Investigating the Safety and Efficacy of Subjects With Alcohol Associated Hepatitis (Part 1) Aldeyra Therapeutics, Inc. NA
COMPLETED
(Jun 1, 2026)
PHASE2 Optimizing Treatment of Co-occurring Smoking and Unhealthy Alcohol Use Among PWH in Nairobi, Kenya University of Chicago NA
NOT YET RECRUITING
(Jun 1, 2026)
PHASE3 Effects of Ketones on Brain Energetics and Alcohol Consumption in Alcohol Use Disorder University of Pennsylvania NA
NOT YET RECRUITING
(Jun 1, 2026)
PHASE2, PHASE3 Mindfulness Meditation for Insomnia Brigham and Women's Hospital NA
RECRUITING
(Jun 1, 2026)
PHASE1, PHASE2 Brain-Computer Interface Visualization Training to Optimize Muscle Activation Following Orthopaedic Surgery Rush University Medical Center NA
RECRUITING
(Jun 1, 2026)
PHASE2 Phase 2 Study of Apremilast in Women and Men With Alcohol Use Disorder Yale University NA
RECRUITING
(Jun 1, 2026)
PHASE2 MDMA-Assisted Therapy for Veterans With PTSD and Alcohol Use Disorder VA Office of Research and Development NA
RECRUITING
(Jun 1, 2026)
PHASE2, PHASE3 Boosting Olfactory and Sensory Training Study (BOOST) University of Alabama at Birmingham NA
RECRUITING
(Jun 1, 2026)
PHASE2 Behavioral Economic Attributes of Recreation Rush University Medical Center NA
RECRUITING
(Jun 1, 2026)
PHASE1, PHASE2 A Study of Chiglitazar in Patients With Metabolic Dysfunction-associated Steatohepatitis and Type 2 Diabetes Mellitus Shanghai Jiao Tong University School of Medicine NA
RECRUITING
(Jun 1, 2026)
PHASE2 Nasal Inhalation of Isopropyl Alcohol for the Treatment of Nausea in Patients With Cancer M.D. Anderson Cancer Center NA
NOT YET RECRUITING
(May 1, 2026)
PHASE2 Citicoline in Youth Alcohol Use Disorder Medical University of South Carolina NA
ACTIVE NOT RECRUITING
(May 1, 2026)
PHASE2 Bicalutamide Therapy in Young Women With NAFLD and PCOS University of California, San Francisco NA
RECRUITING
(May 1, 2026)
PHASE1 Guanfacine for Alcohol Use Disorder (AUD) Indiana University NA
RECRUITING
(May 1, 2026)
PHASE2 Door-Through-Door Companion Rideshare Technology for Individuals With Alzheimer's Disease and Related Dementias (AD/ADRD) Onward Health, Inc NA
ACTIVE NOT RECRUITING
(May 1, 2026)
PHASE1 Evaluating the Safety and Efficacy of Carbocisteine in the Treatment of Nonalcoholic Fatty Liver Disease Patients Tanta University NA
RECRUITING
(May 1, 2026)
PHASE2 GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV Vanderbilt University Medical Center NA
RECRUITING
(May 1, 2026)
PHASE2 Acute Effects of Cannabis on Cognition and Affect Washington State University NA
NOT YET RECRUITING
(May 1, 2026)
PHASE2 A Study of Efimosfermin Alfa in Adults With Hepatic Impairment GlaxoSmithKline NA
RECRUITING
(May 1, 2026)
PHASE1 LSD Treatment for Persons With Alcohol Use Disorder Felix Mueller NA
RECRUITING
(Apr 1, 2026)
PHASE2 Examining Mu Opioid Mechanisms of Ketamine's Rapid Effects in OCD (MKET2) Stanford University NA
RECRUITING
(Apr 1, 2026)
PHASE2 Integration of Cognitive Processing Therapy and Relapse Prevention for Alcohol Use Disorder and PTSD Texas A&M University NA
RECRUITING
(Apr 1, 2026)
PHASE2 Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 2 Yale University NA
ACTIVE NOT RECRUITING
(Apr 1, 2026)
PHASE2 Effect of Nutritional Ketosis on Alcohol Metabolism University of Pennsylvania NA
ACTIVE NOT RECRUITING
(Apr 1, 2026)
PHASE2, PHASE3 Ketamine for Combined Depression and Alcohol Use Disorder University Hospital of North Norway NA
RECRUITING
(Apr 1, 2026)
PHASE1, PHASE2 Study of the BIOPIN 6 Naltrexone Implant in Healthy Adults Akyso Therapeutics, LLC NA
COMPLETED
(Apr 1, 2026)
PHASE1 A Study to Test Whether Survodutide Helps People Living With Obesity or Overweight and With a Confirmed or Presumed Liver Disease Called Non-alcoholic Steatohepatitis (NASH) to Reduce Liver Fat and to Lose Weight (SYNCHRONIZE-MASLD) Boehringer Ingelheim NA
COMPLETED
(Apr 1, 2026)
PHASE3 Motivation for IV Alcohol Self-Administration in Humans University of California, Los Angeles NA
RECRUITING
(Apr 1, 2026)
PHASE2 A Study to Investigate the Safety and Efficacy of TMP-301 Compared to Placebo in Adult Patients With Alcohol Use Disorder Tempero Bio, Inc. NA
TERMINATED
(Apr 1, 2026)
PHASE2 Efficacy of a Smartphone-Based JITAI to Reduce Drinking Among Adults Experiencing Homelessness University of Oklahoma NA
RECRUITING
(Apr 1, 2026)
PHASE2, PHASE3 Extended-release Sodium Oxybate (Lumryz) in Spasmodic Dysphonia and Voice Tremor Kristina Simonyan NA
NOT YET RECRUITING
(Apr 1, 2026)
PHASE1 Ipilimumab and Nivolumab With SBRT in Locally Advanced Hepatocellular Cancer University of Hawaii NA
RECRUITING
(Apr 1, 2026)
PHASE1 Targeted Naltrexone to Support Individuals Participating in Dry January Brigham and Women's Hospital NA
COMPLETED
(Apr 1, 2026)
PHASE2 Clindamycin as an Alternative to Vancomycin in Patients Undergoing Aortic Cardiac Surgery With Extracorporeal Circulation (ECC) Nantes University Hospital NA
RECRUITING
(Apr 1, 2026)
PHASE2 Cannabidiol for the Treatment of Diabetic Peripheral Neuropathy: Pilot Study Florida A&M University NA
RECRUITING
(Apr 1, 2026)
PHASE1, PHASE2 A Phase 1 Comparative Study to Evaluate Pharmacokinetics, Immunogenicity, Safety and Tolerability of Bmab3000 and Herceptin Hylecta® After a Single 600 mg SC Injection in Healthy Male Volunteers Biocon Biologics UK PLC NA
RECRUITING
(Apr 1, 2026)
PHASE1 Human Laboratory Study of Apremilast for Alcohol Use Disorder National Institute on Alcohol Abuse and Alcoholism (NIAAA) NA
RECRUITING
(Apr 1, 2026)
PHASE2 Sleep Health in U.S. Marines San Diego State University NA
RECRUITING
(Apr 1, 2026)
PHASE2 MDMA for Co-occurring PTSD and OUD After Childbirth University of New Mexico NA
RECRUITING
(Mar 1, 2026)
PHASE2 Low-dose Naltrexone for Post-COVID Fatigue Syndrome Luis Nacul NA
COMPLETED
(Mar 1, 2026)
PHASE2 A First in Human Study of CMND-100 in Healthy and Alcohol Use Disorder (AUD) Subjects Clearmind Medicine Inc. NA
RECRUITING
(Mar 1, 2026)
PHASE1, PHASE2 The Effectiveness of CBD and CBN in the Treatment of Facial Pain and Headache of Muscular Origin Wroclaw Medical University NA
ENROLLING BY INVITATION
(Mar 1, 2026)
PHASE2, PHASE3 Impact of Soymilk on Liver Disease Severity of Children With Non-alcoholic Fatty Liver Disease (NAFLD) Marialena Mouzaki NA
RECRUITING
(Mar 1, 2026)
PHASE2 Effects of Ketone Supplementation on Acute Alcohol Withdrawal University of Pennsylvania NA
ENROLLING BY INVITATION
(Mar 1, 2026)
PHASE2, PHASE3 miroliverELAP® for the Treatment of Acute Liver Failure: A Phase 1 Trial Miromatrix Medical Inc. NA
COMPLETED
(Mar 1, 2026)
PHASE1 A Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of VSA006 in Chinese NASH Patients Visirna Therapeutics HK Limited NA
ACTIVE NOT RECRUITING
(Mar 1, 2026)
PHASE2 Digoxin In NASH (CODIN) Yale University NA
RECRUITING
(Mar 1, 2026)
PHASE2 ACT_for Alcohol Use Disorder and Depression Centre hospitalier de l'Université de Montréal (CHUM) NA
RECRUITING
(Mar 1, 2026)
Effects of Ketone Supplement and Alcohol on Brain Metabolism University of Pennsylvania NA
RECRUITING
(Mar 1, 2026)
PHASE2, PHASE3 Probenecid Administration for Alcohol Craving and Consumption Brown University NA
RECRUITING
(Mar 1, 2026)
PHASE2 Observational Study on GER in Patients With Simple Obesity Jing Ma NA
COMPLETED
(Mar 1, 2026)
Trial of CS060380 Tablets for Non-alcoholic Steatohepatitis (NASH) Cascade Pharmaceuticals, Inc NA
RECRUITING
(Mar 1, 2026)
PHASE2 
